title: Serum sulfhydryl levels in rheumatoid patients treated with cyclophosphamide.
abstract: Six months' cyclophosphamide treatment significantly increased the sulfhydryl (SH) serum levels in all 12 rheumatoid arthritis (RA) patients studied and significantly decreased the PIP joints' technetium index (Tc-index), the erythrocyte sedimentation rate (ESR), and the joint count.
mesh_terms: D000328:Adult; D001172:Arthritis, Rheumatoid / Q000097:blood / Q000188:drug therapy*; D001799:Blood Sedimentation; D003520:Cyclophosphamide / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007970:Leukopenia / Q000139:chemically induced; D008297:Male; D008875:Middle Aged; D013438:Sulfhydryl Compounds / Q000097:blood*; D013667:Technetium
chemical_list: D013438:Sulfhydryl Compounds; D013667:Technetium; D003520:Cyclophosphamide